Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Markus Beier"'
Autor:
Andrea S Bauer, Andreas Keller, Eithne Costello, William Greenhalf, Melanie Bier, Anne Borries, Markus Beier, John Neoptolemos, Markus Büchler, Jens Werner, Nathalia Giese, Jörg D Hoheisel
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e34151 (2012)
A solid process for diagnosis could have a substantial impact on the successful treatment of pancreatic cancer, for which currently mortality is nearly identical to incidence. Variations in the abundance of all microRNA molecules from peripheral bloo
Externí odkaz:
https://doaj.org/article/985d6fe8db0d4ba8ab7e9806fae09b86
Autor:
Thorsten Wiechmann, Markus Beier
Publikováno v:
Raumforschung und Raumordnung, Vol 62, Iss 6 (2004)
In the 1990ies Regional Development Concepts have become a mainstream tool in the German Länder, mostly without a systematic review of their performance. Before this background the article deals with the neglected challenge of evaluations in regiona
Externí odkaz:
https://doaj.org/article/017b2853cdd6474abe9f640c6dfb549d
Autor:
Markus Beier
Publikováno v:
Mmw Fortschritte Der Medizin
Autor:
Björn Stade, Lotte Moens, Joachim Fritzsche, Sascha Sauer, Tom Brown, Xia Teng, David Stoddart, Anders Kristensen, Kalim U. Mir, Afaf H. El-Sagheer, Andre Franke, Nadine Schracke, Jonas O. Tegenfeldt, Mats Nilsson, Elin Falk-Sörqvist, Andrew John Heron, Jane Kaye, Giovanni Maglia, Nathalie Zahra, Abdou ElSharawy, Colin Veal, Rodolphe Marie, Fredrik Persson, Jonathan Mangion, Marco Mignardi, Joop M.L.M. van Helvoort, Jörg Tost, Dvir Rotem, Ivo Gut, Hagan Bayley, Achillefs N. Kapanidis, Vincent Picaud, Spencer J. Gibson, Liqin Dong, Thomas Brefort, Henrik Flyvbjerg, Markus Beier, Emile Schyns, Johannes Hohlbein, Pieter Jan Van Der Zaag, Florence Mauger, Jelle Oostmeijer, Peter Freeman, Simon Heath, Geraint Evans, Owen Lancaster, Hans Lehrach, Simone Guenther, Michael Forster, David L.V. Bauer, Rongqin Ke, Jennifer Sengenes, Steven McGinn, Jonas Nyvold Pedersen, Marta Gut, Isabelle Heath-Brun, Ludovic Le Reste, Camilla Freitag, Anthony J. Brookes, Björn Ekström, Simon Fredriksson, Mats Gullberg, Florian Mertes, James P Willcocks, Peer F. Stähler, Ruud Out, Cees Dekker
Publikováno v:
New Biotechnology, 33(3), 311-330. ELSEVIER SCIENCE BV
New Biotechnology, 33(3), 311-330
New Biotechnology 33 (2016) 3
New Biotechnology
New Biotechnology, 2016, 33 (3), pp.311-330. ⟨10.1016/j.nbt.2015.10.003⟩
New Biotechnology, 33(3), 311-330
New Biotechnology 33 (2016) 3
New Biotechnology
New Biotechnology, 2016, 33 (3), pp.311-330. ⟨10.1016/j.nbt.2015.10.003⟩
International audience; The REvolutionary Approaches and Devices for Nucleic Acid analysis (READNA) project received 12 million s funding under the European Union Framework Programme 7 from 1st June 2008 to 30th November 2012. The 19 project partners
Autor:
Eckart Meese, Valentina Galata, Andreas Keller, Jochen Kohlhaas, Hanno Huwer, Thomas Brefort, Medea Krapp, Christina Backes, Markus Beier, Petra Leidinger
Publikováno v:
Oncotarget
Validation of biomarkers is essential to advance the translational process to clinical application. Although there exists an increasing number of reports on small non-coding RNAs (microRNAs) as minimally-invasive markers from blood, serum or plasma,
Autor:
Andreas Keller, Patrick Küry, Britta Wingerath, Markus Beier, Derya Kaya, Til Menge, Thomas Dehmel, Bernd C. Kieseier, Christina Backes, Hans-Peter Hartung, Jens Ingwersen, Jonas Graf, Tim Prozorovski, Orhan Aktas, Matthias Scheffler
Publikováno v:
Annals of Clinical and Translational Neurology
Objective: To identify microRNAs (miRNAs) regulated by anti-alpha 4 integrin monoclonal antibody therapy (natalizumab) in the peripheral blood of patients with relapsing-remitting (RR) multiple sclerosis (MS) and to confirm their role in experimental
Autor:
Stefan E. Hardt, Benjamin Meder, Andreas Keller, Hugo A. Katus, Sabine Marquart, Britta Vogel, Markus Beier, Farbod Sedaghat-Hamedani, Karen S. Frese, Evangelos Giannitsis, Elham Kayvanpour, Sarah Hassel, Wanda Kloos
Publikováno v:
Clinical Chemistry. 59:410-418
BACKGROUND Alterations in microRNA (miRNA) expression patterns in whole blood may be useful biomarkers of diverse cardiovascular disorders. We previously reported that miRNAs are significantly dysregulated in acute myocardial infarction (AMI) and app
Autor:
Stefan E. Hardt, Benjamin Meder, Britta Vogel, Christina Backe, Eckart Meese, Petra Leidinger, Andreas Keller, Farbod Sedaghat-Hamedani, Hugo A. Katus, Thomas Brefort, Markus Beier, Ann Thanaraj, Karen S. Frese, Wanda Kloos, Elham Kayvanpour
Publikováno v:
European Heart Journal; Vol 34
European Heart Journal
European Heart Journal
Aims Non-ischaemic heart failure is one of the today's most prevalent cardiovascular disorders. Since modern pharmacotherapy has proved to be very effective in delaying disease progression and preventing death, imaging modalities and molecular biomar
Autor:
Markus Beier, Jakob Manthey, Jose Angel Arbesu Prieto, Didier Duhot, Alessandro Rossi, José Zarco, Michael Bachmann, Jürgen Rehm, Ludwig Kraus, Carsten Grimm, Emanuele Scafato, Henri-Jean Aubin, Antoni Gual, Bernd Schulte
Publikováno v:
BMC Family Practice
Background Even though addressing lifestyle problems is a major recommendation in most guidelines for the treatment of hypertension (HTN), alcohol problems are not routinely addressed in the management of hypertension in primary health care. Methods
Autor:
Christiane Heid, Benjamin Meder, Dieter Weichenhan, Bernhard Korn, Anne Borries, Arne Pfeufer, Valesca Boisguerin, Steffen Just, Markus Beier, Andreas Keller, Wolfgang Rottbauer, Maren Scharfenberger-Schmeer, Tim M. Strom, Peer F. Stähler, Jan Haas, Hugo A. Katus
Publikováno v:
Circulation: Cardiovascular Genetics
Circ. Cardiovasc. Genet. 4, 110-122 (2011)
Circulation: Cardiovascular Genetics; Vol 4
Circ. Cardiovasc. Genet. 4, 110-122 (2011)
Circulation: Cardiovascular Genetics; Vol 4
Background— Today, mutations in more than 30 different genes have been found to cause inherited cardiomyopathies, some associated with very poor prognosis. However, because of the genetic heterogeneity and limitations in throughput and scalability